Clarus Corp

CLAR remains in a medium-term Stage 4 decline with bearish structure, but a recent momentum breakout has extended price above the EMAs without clear exhaustion. In the absence of mean-reversion eligibility and with overbought conditions, there is no favorable sell entry now. We defer execution and plan to trim into the overhead EMA resistance zone.

• ↑Q2 revenue rose 1.6% YoY to $56.2M; gross margin up to 48.9% from 35.6%.
• ↑Net income $4.7M vs prior‐year loss; Adjusted EBITDA jumped to $7.6M.
• ↓Negative earnings yield (-0.75) and weak profitability raise red flags.